Peer-Reviewed Journal Details
Mandatory Fields
Enright EF;Gahan CG;Joyce SA;Griffin BT;
2016
September
The Yale journal of biology and medicine
The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Validated
()
Optional Fields
89
3
The significance of the gut microbiota as a determinant of drug pharmacokinetics and accordingly therapeutic response is of increasing importance with the advent of modern medicines characterised by low solubility and/or permeability, or modified-release. These physicochemical properties and release kinetics prolong drug residence times within the gastrointestinal tract, wherein biotransformation by commensal microbes can occur. As the evidence base in support of this supplementary metabolic "organ" expands, novel opportunities to engineer the microbiota for clinical benefit have emerged. This review provides an overview of microbe-mediated alteration of drug pharmacokinetics, with particular emphasis on studies demonstrating proof of concept in vivo. Additionally, recent advances in modulating the microbiota to improve clinical response to therapeutics are explored.
1551-4056
Grant Details